Literature DB >> 18336360

A docking modelling rationally predicts strong binding of bisphenol A to estrogen-related receptor gamma.

Takeru Nose1, Yasuyuki Shimohigashi.   

Abstract

A computer-aided docking study was carried out to quickly clarify the binding structure of the ligand-receptor complex between bisphenol A (BPA), a well-known endocrine disruptor, and estrogen-related receptor gamma (ERRgamma). The resulting complex indicated that BPA binds to the ligand-binding pocket of ERRgamma without any disruptions of the activation conformation.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18336360     DOI： 10.2174/092986608783744261

Source DB:  PubMed          Journal:  Protein Pept Lett        ISSN： 0929-8665            Impact factor:   1.890


  4 in total

Review 1.  A structural view of nuclear hormone receptor: endocrine disruptor interactions.

Authors:  Albane le Maire; William Bourguet; Patrick Balaguer
Journal:  Cell Mol Life Sci       Date:  2010-01-09       Impact factor: 9.261

2.  Designing Endocrine Disruption Out of the Next Generation of Chemicals.

Authors:  T T Schug; R Abagyan; B Blumberg; T J Collins; D Crews; P L DeFur; S M Dickerson; T M Edwards; A C Gore; L J Guillette; T Hayes; J J Heindel; A Moores; H B Patisaul; T L Tal; K A Thayer; L N Vandenberg; J Warner; C S Watson; F S Vom Saal; R T Zoeller; K P O'Brien; J P Myers
Journal:  Green Chem       Date:  2013-01       Impact factor: 10.182

Review 3.  Estrogenic environmental chemicals and drugs: mechanisms for effects on the developing male urogenital system.

Authors:  Julia A Taylor; Catherine A Richter; Rachel L Ruhlen; Frederick S vom Saal
Journal:  J Steroid Biochem Mol Biol       Date:  2011-07-30       Impact factor: 4.292

4.  Tualang Honey Protects against BPA-Induced Morphological Abnormalities and Disruption of ERα, ERβ, and C3 mRNA and Protein Expressions in the Uterus of Rats.

Authors:  Siti Sarah Mohamad Zaid; Normadiah M Kassim; Shatrah Othman
Journal:  Evid Based Complement Alternat Med       Date:  2015-12-14       Impact factor: 2.629
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.